Sort
82,697 grants matching “vaccine development”
Understanding measles vaccine failure (and success) in Southern India
$768,754Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2018 · AI
Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit
$768,735Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · U01 · FY2009 · AI
Novel diagnostic tools and animal model system for study human/animal interface of COVID-19
$768,711Ying Fang · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI
VACCINE TREATMENT AND EVALUATION UNIT:CONCEPT AND PROTOCOL DEVELOPMENT
$768,693Clarence Buddy Creech · · N01 · FY2017 · AI
Application of a syndemic framework to HPV and HSV infection in emergent adult men
$768,654Danielle C Ompad · New York University · R01 · FY2019 · AI
Task C32: Model Refinement in Pig-Tailed Macaques to AssessTherapeutics for Chlamydia trachomatis
$768,645Hanne Elyard · Bioqual, Inc. · N01 · FY2017 · AI
Malaria Pathogenesis and Human Immunity
$768,635Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$768,623Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Impact of eliminating nonmedical exemptions in California
$768,610Saad B. Omer · Emory University · R01 · FY2017 · AI
Antigen Design, Production and Vaccine Development
$768,541Michael W Cho · Iowa State University · P01 · FY2011 · AI
REstoring mental health after COVID-19 through commUnity-based Psychological services in New York City (RECOUP-NY)
$768,515Brandon Alan Kohrt · George Washington University · R01 · FY2021 · MH
DEVELOPING MULTI-ANTIGEN VACCINE FOR THE TREATMENT OF CHRONIC HBV
$768,496Valerian Nakaar · Carogen Corporation · R44 · FY2020 · DK
Squirrel Monkey Breeding and Research Resource
$768,371Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2016 · OD
Squirrel Monkey Breeding and Research Resource
$768,371Lawrence E Williams · University Of Tx Md Anderson Can Ctr · P40 · FY2019 · OD
CD4 T cell-targeted nanoparticle in vivo delivery of CRISPR/Cas9 genome editors for HIV cure
$768,325Wenhui Hu · Temple Univ Of The Commonwealth · R01 · FY2020 · AI
Antisense Mediated Treatment of Hepatitis B Virus Infection
$768,305Stefan Frank Wieland · Scripps Research Institute, The · R01 · FY2012 · AI
A revolutionary vaccine approach to prevent HIV infection in substance abuse
$768,300Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2015 · DA
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention
$768,180Anna Aldovini · Boston Children'S Hospital · R01 · FY2016 · DE
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$768,169Chiara Giannarelli · New York University School Of Medicine · R01 · FY2024 · HL
Mechanisms controlling the persistence of infectious HIV reservoirs in children
$768,168Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2019 · HD
BSL-3 Practices Core
$768,114Jeffrey Joseph Adamovicz · University Of Missouri-Columbia · UC7 · FY2023 · AI
Prevention of AIDS
$768,111Barbara Felber · Basic Sciences · Z01 · FY2007 · CA
Project 3 -Translational development of a microneedle patch gonorrhea vaccine (CIIG)
$768,062Emrullah Korkmaz · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2025 · AI
Defining Critical Sites of Vulnerability and Correlates of Protection to Kaposi Sarcoma Associated Herpesvirus to Inform Vaccine Design
$768,047Andrew McGuire · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Vector Production Core
$768,040Norman L Letvin · Duke University · U19 · FY2008 · AI